Outcome of pregnancy after clomiphene therapy

Acta Obstetricia Et Gynecologica Scandinavica, 55(4), 371-375

DOI 10.3109/00016347609158516 PMID 973567

Abstract

Of 159 pregnancies conceived after clomiphene therapy, 141 ended in childbirth, including seven sets of twins. There was a probable increase in the number of infants born with major malformations. These were exclusively to women who had not previously borne a normal infant. The incidence of malformed infants compares well with that published after gonadotropin therapy. The possibly higher incidence of malformations seen after drug-induced ovulation would therefore seem to be due to the underlying subfertility state and thus not a direct drug effect.

Topics

clomiphene therapy pregnancy outcome birth defects, clomiphene citrate congenital malformations risk, ovulation induction drug safety pregnancy outcomes, clomiphene twin pregnancy rate incidence, birth defects after drug induced ovulation subfertility, clomiphene pregnancy malformation rate gonadotropin comparison, Ahlgren Källén clomiphene pregnancy outcome, subfertility underlying cause congenital malformations, clomiphene citrate 159 pregnancies childbirth outcomes, ovulation induction teratogenicity assessment
PMID 973567 973567 DOI 10.3109/00016347609158516 10.3109/00016347609158516

Cite this article

Ahlgren, M., Källén, B., & Rannevik, G. (1976). Outcome of pregnancy after clomiphene therapy. *Acta obstetricia et gynecologica Scandinavica*, *55*(4), 371-375. https://doi.org/10.3109/00016347609158516

Related articles